PSMA-targeted imaging of prostate cancer: evolution of a success story

od Maurer, Tobias, Eiber, Matthias
izdano v Asian J Androl (2017)

A rare case of polyostotic fibrous dysplasia detected on (18)F-rhPSMA-7 PET/CT

od Wang, Hui, Eiber, Matthias, Langbein, Thomas
izdano v Eur J Nucl Med Mol Imaging (2020)

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?

od Maurer, Tobias, Murphy, Declan G., Hofman, Michael S., Eiber, Matthias
izdano v Theranostics (2017)

[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery

od Schottelius, Margret, Wirtz, Martina, Eiber, Matthias, Maurer, Tobias, Wester, Hans-Jürgen
izdano v EJNMMI Res (2015)

Influence of sampling schedules on [(177)Lu]Lu-PSMA dosimetry

od Rinscheid, Andreas, Kletting, Peter, Eiber, Matthias, Beer, Ambros J., Glatting, Gerhard
izdano v EJNMMI Phys (2020)

2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy...

od Herrmann, Ken, Kratochwil, Clemens, Fendler, Wolfgang P., Eiber, Matthias, Hustinx, Roland
izdano v Eur J Nucl Med Mol Imaging (2021)

Current Staging Procedures in Urinary Bladder Cancer

od Maurer, Tobias, Horn, Thomas, Heck, Matthias, Gschwend, Jürgen E., Eiber, Matthias, Beer, Ambros J.
izdano v Diagnostics (Basel) (2013)

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

od Rauscher, Isabel, Maurer, Tobias, Fendler, Wolfgang P., Sommer, Wieland H., Schwaiger, Markus, Eiber, Matthias
izdano v Cancer Imaging (2016)

Double-strand breaks in lymphocyte DNA of humans exposed to [(18)F]fluorodeoxyglucose and the static magnetic field in PET/MRI

od Brix, Gunnar, Günther, Elisabeth, Rössler, Ute, Endesfelder, David, Kamp, Alexandra, Beer, Ambros, Eiber, Matthias
izdano v EJNMMI Res (2020)

The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model

od Begum, Nusrat J., Glatting, Gerhard, Wester, Hans-Jürgen, Eiber, Matthias, Beer, Ambros J., Kletting, Peter
izdano v Sci Rep (2019)

Multiparametric 18F–FDG PET/MR follow-up in a patient with autoimmune pancreatitis

od Rauscher, Isabel, Eiber, Matthias, Algül, Hana, Siveke, Jens T., Weirich, Gregor, Schlitter, Anna M., Beer, Ambros J.
izdano v Eur J Hybrid Imaging (2017)

Radiohybrid Ligands: A Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA Inhibitors

od Wurzer, Alexander, Di Carlo, Daniel, Schmidt, Alexander, Beck, Roswitha, Eiber, Matthias, Schwaiger, Markus, Wester, Hans-Jürgen
izdano v J Nucl Med (2020)

Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients

od Bogdanovic, Borjana, Gafita, Andrei, Schachoff, Sylvia, Eiber, Matthias, Cabello, Jorge, Weber, Wolfgang A., Nekolla, Stephan G.
izdano v Eur J Nucl Med Mol Imaging (2020)

Pre-test (68)Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model

od Kraft, Pia, Maurer, Tobias, Gafita, Andrei, Krönke, Markus, Haller, Bernhard, Weber, Wolfgang A., Eiber, Matthias, Rauscher, Isabel
izdano v EJNMMI Res (2020)

Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?

od Knipper, Sophie, von Amsberg, Gunhild, Stolzenbach, Franziska, Steuber, Thomas, Heck, Matthias, Eiber, Matthias, Berliner, Christoph, Maurer, Tobias
izdano v Asian J Urol (2021)

Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007

od Robu, Stephanie, Schmidt, Alexander, Eiber, Matthias, Schottelius, Margret, Günther, Thomas, Hooshyar Yousefi, Behrooz, Schwaiger, Markus, Wester, Hans-Jürgen
izdano v EJNMMI Res (2018)

Matched-Pair Comparison of (68)Ga-PSMA-11 PET/CT and (18)F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy

od Rauscher, Isabel, Krönke, Markus, König, Michael, Gafita, Andrei, Maurer, Tobias, Horn, Thomas, Schiller, Kilian, Weber, Wolfgang, Eiber, Matthias
izdano v J Nucl Med (2020)

Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET/CT: a bi-centric analysis

od Gafita, Andrei, Calais, Jeremie, Franz, Charlott, Rauscher, Isabel, Wang, Hui, Roberstson, Andrew, Czernin, Johannes, Weber, Wolfgang A., Eiber, Matthias
izdano v EJNMMI Res (2019)

Imaging prostate cancer with PSMA PET/CT and PET/MRI: current and future applications

od Hope, Thomas A., Afshar-Oromieh, Ali, Eiber, Matthias, Emmett, Louise, Fendler, Wolfgang P., Lawhn-Heath, Courtney, Rowe, Steven P.
izdano v AJR Am J Roentgenol (2018)

Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study

od Dewes, Sabrina, Schiller, Kilian, Sauter, Katharina, Eiber, Matthias, Maurer, Tobias, Schwaiger, Markus, Gschwend, Jürgen E., Combs, Stephanie E., Habl, Gregor
izdano v Radiat Oncol (2016)